Ginkgo Bioworks Holdings (DNA) Free Cash Flow Growth (1y) (2021 - 2026)
Powered by 
Analysis
Ginkgo Bioworks Holdings (DNA) Free Cash Flow Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 23.29% |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | -3.03% |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 81.36% |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | -12.22% |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 39.16% |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -16.38% |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -296.50% |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 13.10% |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -16.38% |
| Mar 31, 2026 | 17.79% |
| Dec 31, 2025 | 15.07% |
| Sep 30, 2025 | 73.35% |
| Jun 30, 2025 | 63.84% |
| Mar 31, 2025 | 38.37% |
| Dec 31, 2024 | 8.38% |
| Sep 30, 2024 | -52.17% |
| Jun 30, 2024 | -27.97% |
| Mar 31, 2024 | 12.78% |
| Dec 31, 2023 | 52.93% |
| Sep 30, 2023 | -86.29% |
| Jun 30, 2023 | 20.11% |
| Mar 31, 2023 | -368.63% |
| Dec 31, 2022 | 23.72% |
| Sep 30, 2022 | -291.96% |
| Jun 30, 2022 | -84.89% |
| Mar 31, 2022 | 66.49% |
| Dec 31, 2021 | -116.70% |